Citations

Showing 10 of 108152 citations.

First Report of Proton Beam Therapy in a Patient With a Left Ventricular Assist Device
Schumer, Erin M. , Schettle, Sarah , Stulak, John M., Rosenbaum, Andrew , Rosenbaum, Andrew N

Mayo Clinic

ASAIO Journal | May 14, 2021 | Volume: 68 | Issue: 5 | Pages: e84-e86

10.1097/mat.0000000000001478 | PMID 35503645 Get It

A 77 year old man previously implanted with a HeartMate II left ventricular assist device (LVAD) as destination therapy and an implantable cardioverter defibrillator presented with a left upper lobe squamous cell lung cancer. Oncology determined that proton beam therapy was indicated for treatment, and a multidisciplinary team of radiation physicists, radiation oncologists, and LVAD providers developed a protocol to proceed safely. He was successfully treated with combined proton beam radiation therapy and reduced dose chemotherapy. This case demonstrates feasibility and considerations of proton beam therapy for malignancy relevant to patients with implantable cardiac devices including LVADs.
Regional analgesia in Cardiac anesthesia: Welcoming a new era in perioperative pain management.
Yu, Soojie , Aljure, Oscar , Aljure, Oscar D

Mayo Clinic

No container title available | May 14, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.162101177.74599845/v1 Get It

Energy‐integrating‐detector multi‐energy CT: Implementation and a phantom study
Ren, Liqiang , Allmendinger, Thomas , Halaweish, Ahmed F., Schmidt, Bernhard , Flohr, Thomas , Yu, Lifeng , McCollough, Cynthia H. , Yu, Lifeng

Mayo Clinic

Medical Physics | May 14, 2021 | Volume: 48 | Issue: 9 | Pages: 4857-4871

10.1002/mp.14943 | PMID 33988849 Get It

PurposeMulti‐energy computed tomography (MECT) has a great potential to enable many novel clinical applications such as simultaneous multi‐contrast imaging. The purpose of this study was to implement triple‐beam MECT on a traditional energy‐integrating‐detector (EID) CT platform (EID‐MECT).MethodsThis was accomplished by mounting a z‐axis split‐filter (0.05 mm Au, 0.6 mm Sn) on Tube A of a dual‐source EID CT scanner. With the two split x‐ray beams from Tube A and the third beam from Tube B, three beams with different x‐ray spectra can be simultaneously acquired. With Tube B operated at 70 or 80 kV and Tube A at 120 or 140 kV, four different triple‐beam configurations were calibrated for MECT measurements: 70/Au120/Sn120, 80/Au120/Sn120, 70/Au140/Sn140, and 80/Au140/Sn140 kV. Iodine (I), gadolinium (Gd), bismuth (Bi) samples, and their mixtures were prepared for 2 three‐material‐decomposition tasks and 1 four‐material‐decomposition task. For each task, samples were placed in a water phantom and scanned using each of the four triple‐beam configurations. For comparison, the same phantom was also scanned using three other dual‐energy CT (DECT) or MECT technologies: twin‐beam DECT (TB‐DECT), dual‐source DECT (DS‐DECT), and photon‐counting‐detector CT (PCD‐CT), all with optimal x‐ray spectrum settings and at equal volume CT dose index (CTDIvol). The phantom for four‐material decomposition (I/Gd/Bi/Water imaging) was scanned using the PCD‐CT only (140 kV with 25, 50, 75, and 90 keV). Image‐based material decomposition was performed to acquire material‐specific images, on which the mean basis material concentrations and noise levels were measured and compared across all triple‐beam configurations in EID‐MECT and various DECT/MECT systems.ResultsThe optimal triple‐beam configuration was task‐dependent with 70/Au120/Sn120, 70/Au140/Sn140, and 70/Au120/Sn120 kV for I/Gd/Water, I/Bi/Water, and I/Gd/Bi/Water material decomposition tasks, respectively. At equal radiation dose level, EID‐MECT provided comparable or better quantification accuracy in material‐specific images for all three material decomposition tasks, compared to EID‐based DECT and PCD‐CT systems. In terms of noise level comparison, EID‐MECT‐derived material‐specific images showed lower noise levels than TB‐DECT and DS‐DECT, but slightly higher than that from PCD‐CT in I/Gd/Water imaging. For I/Bi/Water imaging, EID‐MECT showed a comparable noise level to DS‐DECT, and a much lower noise level than TB‐DECT and PCD‐CT in all material‐specific images. For the four‐material decomposition task involving I/Gd/Bi/Water, the bismuth‐specific image derived from EID‐MECT was slightly noisier, but both iodine‐ and gadolinium‐specific images showed much lower noise levels in comparison to PCD‐CT.ConclusionsFor the first time, an EID‐based MECT system that can simultaneously acquire three x‐ray spectra measurements was implemented on a clinical scanner, which demonstrated comparable or better imaging performance than existing DECT and MECT systems.
Nanoprojectile Secondary Ion Mass Spectrometry for Analysis of Extracellular Vesicles
Verkhoturov, Dmitriy S., Crulhas, Bruno P. , Eller, Michael J. , Han, Yong Duk, Verkhoturov, Stanislav V. , Bisrat, Yordanos, Revzin, Alexander , Han, Yong D, Schweikert, Emile A , Eller, Michael J

Mayo Clinic

Analytical Chemistry | May 14, 2021 | Volume: 93 | Issue: 20 | Pages: 7481-7490

10.1021/acs.analchem.1c00689 | PMID 33988360 Get It

Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
Park, JooYong , Choi, Ji‐Yeob , Chung, Seokang , Song, Nan , Park, Sue K. , Han, Wonshik , Noh, Dong‐Young , Ahn, Sei-Hyun, Lee, Jong Won, Kim, Mi Kyung , Jee, Sun Ha , Wen, Wanqing , Bolla, Manjeet K. , Wang, Qin , Michailidou, Kyriaki , Shah, Mitul , Conroy, Don, Harrington, Patricia, Mayes, Rebecca , Hall, Per , Patel, Alpa V. , Couch, Fergus J. , Sawyer, Elinor J. , Roylance, Rebecca , Bojesen, Stig E. , Flyger, Henrik, Lambrechts, Diether , Baten, Adinda , Matsuo, Keitaro , Ito, Hidemi , Guénel, Pascal , Keeman, Renske , Schmidt, Marjanka K. , Wu, Anna H. , Tseng, Chiu-Chen, Cox, Angela , Investigators, kConFab, Andrulis, Irene L. , Hopper, John L., Wu, Pei‐Ei , Shen, Chen‐Yang , Fasching, Peter A. , Ekici, Arif B. , Muir, Kenneth, Brenner, Hermann , Arndt, Volker , Jones, Michael E. , Swerdlow, Anthony J, Hoppe, Reiner , Ko, Yon-Dschun, Hartman, Mikael , Li, Jingmei , Mannermaa, Arto, Hartikainen, Jaana M. , Benítez, Javier, Haiman, Christopher A. , Dörk, Thilo , Bogdanova, Natalia , Teo, Soo‐Hwang , Taib, Nur Aishah Mohd , Fletcher, Olivia, Johnson, Nichola , Grip, Mervi, Winqvist, Robert , Nevanlinna, Heli , Lindblom, Annika , Wendt, Camilla, Kristensen, Vessela N. , Collaborators, NBCS, Tollenaar, Rob A.�E.�M. , Heemskerk‐Gerritsen, Bernadette A. M. , Bonanni, Bernardo , Hamann, Ute, Manoochehri, Mehdi, Martinez, Maria Elena, Easton, Douglas F., Yoo, Keun-Young, Lambrechts, Diether , Song, Nan , Park, Sue K , Kim, Mi Kyung , Dennis, Joe , Michailidou, Kyriaki , Hall, Per N , Matsuo, Keitaro , Ito, Hidemi , Keeman, Renske , Schmidt, Marjanka K , Fasching, Peter A , Brenner, Hermann , Arndt, Volker , Hartikainen, Jaana M , Dörk, Thilo , Bogdanova, Natalia V , Johnson, Nichola , Nevanlinna, H , Heemskerk-Gerritsen, Bernadette A M , Bonanni, Bernardo , Lambrechts, Diether , Teo, Soo H , Jones, Michael E , Lambrechts, Diether , Cox, Angela , Guénel, Pascal , Hartman, Mikael , Li, Jingmei , Ekici, Arif B , Bojesen, Stig E , Lindblom, Annika , Mohd Taib, Nur Aishah , Sawyer, Elinor J , Choi, Jaesung , Czene, Kamila , Teras, Lauren R. , Couch, Fergus J. , Olson, Janet E. , Truong, Thérèse , Cross, Simon S. , Investigators, kConFab, Southey, Melissa C. , Lophatananon, Artitaya , Ko, Yon‐Dschun, Mannermaa, Arto , González‐Neira, Anna , Fletcher, Olivia , Blomqvist, Carl , Wendt, Camilla, Collaborators, NBCS, Radice, Paolo , Manoochehri, Mehdi, Lacey, James V. , Dunning, Alison M. , Pharoah, Paul D.P. , Kang, Daehee

Mayo Clinic

Cancers | May 14, 2021 | Volume: 13 | Issue: 10 | Pages: 2370

10.3390/cancers13102370 | PMID 34069208 Get It

In this study we aim to examine gene–environment interactions (GxEs) between genes involved with estrogen metabolism and environmental factors related to estrogen exposure. GxE analyses were conducted with 1970 Korean breast cancer cases and 2052 controls in the case-control study, the Seoul Breast Cancer Study (SEBCS). A total of 11,555 SNPs from the 137 candidate genes were included in the GxE analyses with eight established environmental factors. A replication test was conducted by using an independent population from the Breast Cancer Association Consortium (BCAC), with 62,485 Europeans and 9047 Asians. The GxE tests were performed by using two-step methods in GxEScan software. Two interactions were found in the SEBCS. The first interaction was shown between rs13035764 of NCOA1 and age at menarche in the GE|2df model (p-2df = 1.2 × 10−3). The age at menarche before 14 years old was associated with the high risk of breast cancer, and the risk was higher when subjects had homozygous minor allele G. The second GxE was shown between rs851998 near ESR1 and height in the GE|2df model (p-2df = 1.1 × 10−4). Height taller than 160 cm was associated with a high risk of breast cancer, and the risk increased when the minor allele was added. The findings were not replicated in the BCAC. These results would suggest specificity in Koreans for breast cancer risk.
Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance
Click, Benjamin , Merchea, Amit , Regueiro, Miguel , Stocchi, Luca , Colibaseanu, Dorin T, Regueiro, Miguel , Colibaseanu, Dorin , Farraye, Francis A.

Mayo Clinic

Inflammatory Bowel Diseases | May 14, 2021 | Volume: 28 | Issue: 2 | Pages: 289-298

10.1093/ibd/izab081 | PMID 33988234 Get It

AbstractIleocolic resection (ICR) is the most common surgical procedure in Crohn disease (CD). There are many surgical techniques for performing ICRs and subsequent anastomoses. Recurrence of CD after ICR is common, often clinically silent, and thus requires monitoring including periodic use of endoscopy to detect early active disease. There is emerging evidence that surgical approaches may influence CD recurrence. This review explores the various surgical considerations, the data behind each decision, and how these techniques influence subsequent endoscopic surveillance.
The Impact of Alcohol in Inflammatory Bowel Diseases
White, Bradley , Ramos, Guilherme Piovezani , Kane, Sunanda V. , White, Bradley A , Kane, S , Ramos, Guilherme P

Mayo Clinic

Inflammatory Bowel Diseases | May 14, 2021 | Volume: 28 | Issue: 3 | Pages: 466-473

10.1093/ibd/izab089 | PMID 33988227 Get It

AbstractSeveral environmental factors have been implicated in the pathogenesis of inflammatory bowel diseases (IBD); however, the evidence for alcohol is sparse, as is its implications on disease activity and overall management. Here, we examine the available evidence for the effect of alcohol on IBD, including its association with the development of IBD, role in exacerbations, and potential medication interactions. Several mechanisms have been demonstrated to mediate the effects of ethanol in the gastrointestinal tract. Alcohol has been shown to alter the gut microbiome, disrupt intestinal barrier, and increase intestinal permeability, directly and indirectly promoting immune activation. Conversely, specific alcoholic beverages, notably red wine, may have anti-inflammatory properties capable of assisting in disease control and affecting disease monitoring. Nonetheless, most alcohol-mediated effects seem to facilitate intestinal inflammation and consequently impact disease onset, recurrence, and symptom control. Furthermore, alcohol use interferes with the metabolism of several medications leading to increased side effect profiles or even loss of effect. Notably, mesalamine, azathioprine, methotrexate, and biologic medications can all be affected by concomitant alcohol intake via a variety of mechanisms.
Inclusion of Albumin in the Initial Resuscitation of Adult Patients with Medical Sepsis or Septic Shock: a Propensity Score-Matched Analysis
Liu, Chang, Li, Heyi , Peng, Zhiyong , Hu, Bo, Gao, Xiaolan, Frank, Ryan D. , Gajic, Ognjen, Hu, Bo , Liu, Chang, Hu, Bo, Dong, Yue , Gao, Xiaolan, Kashyap, Rahul , Gajic, Ognjen, Kashani, Kianoush

Mayo Clinic

Shock | May 14, 2021 | Volume: 56 | Issue: 6 | Pages: 956-963

10.1097/shk.0000000000001810 | PMID 33988539 Get It

ABSTRACT Introduction: The impact of albumin resuscitation on sepsis outcomes is debated, particularly in the initial phase of resuscitation. We aimed to investigate the association between albumin use in the initial 6 h of resuscitation and subsequent outcomes in adult septic patients. Methods: This single-center, retrospective, propensity score-matched cohort study included adult patients admitted to intensive care units (ICUs) with sepsis or septic shock from January 1, 2006, to May 4, 2018, at a tertiary referral hospital. We compared two groups based on albumin receipt within the initial six resuscitation hours (albumin group vs. non-albumin group). We performed a 1:2 propensity score matching to assess shock-free time in ICU as the primary outcome. Results: Of 2,732 patients with medical sepsis, 286 cases in the albumin group were matched with 549 individuals in the non-albumin group. Compared to the non-albumin group, the albumin group required more intravenous fluids and had higher net fluid balance, lower mean arterial pressure, and lower serum base excess level in the initial 6 and 24 h of resuscitation. Shock-free time, ICU and hospital length of stay, and 28-day mortality were not different between albumin and non-albumin groups (56 vs. 66 h, P = 0.18; 3.5 days vs. 3.7 days, P = 0.61; 9.1 days vs. 9.5 days, P = 0.27; 36% vs. 32%, P = 0.25, respectively). Conclusions: Using albumin during the initial 6 h of resuscitation was not associated with benefits in clinical outcomes of patients with medical sepsis.
Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock
Jentzer, Jacob C., Kashani, Kianoush B., Wiley, Brandon M., Patel, Parag C., Baran, David A., Barsness, Gregory W., Henry, Timothy D., Diepen, Sean Van, Jentzer, Jacob C., Kashani, Kianoush B., Wiley, Brandon M., Patel, Parag C., Baran, David A., Barsness, Gregory W., Henry, Timothy D., Diepen, Sean Van

Mayo Clinic

Shock | May 14, 2021 | Volume: 57 | Issue: 1 | Pages: 31-40

10.1097/shk.0000000000001812 | PMID 33988540 Get It

ABSTRACT Background: Acidosis and higher lactate predict worse outcomes in cardiogenic shock (CS) patients. We sought to determine whether overall acidosis severity on admission predicted in-hospital mortality in CS patients. Methods: This retrospective descriptive analysis included CS patients admitted to a single academic tertiary cardiac intensive care unit from 2007 to 2015. Admission arterial pH, base excess, and anion gap values were used to generate a Composite Acidosis Score (range 0–5, with a score ≥2 defining Severe Acidosis). Adjusted in-hospital mortality was analyzed using multivariable logistic regression. Results: We included 1,065 patients with median age of 68.9 (59.0, 77.2) years (36.4% females). Concomitant diagnoses included cardiac arrest in 38.1% and acute coronary syndrome in 59.1%. Severe Acidosis was present in 35.2%, and these patients had worse shock and more organ failure. In-hospital mortality occurred in 34.1% and was higher among patients with Severe Acidosis (54.9% vs. 22.4%, adjusted odds ratio [OR] 2.01, 95% CI 1.43–2.83, P < 0.001). Increasing Composite Acidosis Score was associated with higher in-hospital mortality (adjusted OR 1.25 per point, 95% CI 1.11–1.40, P < 0.001). Severe Acidosis was associated with higher hospital mortality at every level of shock severity and organ failure (all P < 0.05). Admission lactate level had equivalent discrimination for in-hospital mortality as the Composite Acidosis Score (0.69 vs. 0.66; P = 0.32 by De Long test). Conclusion: Given its incremental association with higher in-hospital mortality among CS patients beyond shock severity and organ failure, we propose Severe Acidosis as a marker of hemometabolic shock. Lactate levels performed as well as a composite measure of acidosis for predicting mortality.
Symptom-specific differential motor network modulation by deep brain stimulation in Parkinson’s disease
Gibson, William S. , Rusheen, Aaron E. , In, Myung‐Ho, Gorny, Krzysztof R. , Felmlee, Joel P. , Klassen, Bryan T. , Jung, Sung Jun , Min, Hoon‐Ki , Lee, Kendall H. , In, Myung‐Ho , Min, Hoon-Ki Paul , In, Myung-Ho , Gibson, William S., Oh, Yoonbae , Jo, Hang Joon

Mayo Clinic

Journal of Neurosurgery | May 14, 2021 | Volume: 135 | Issue: 6 | Pages: 1771-1779

10.3171/2020.10.jns202277 | PMID 33990083 Get It

OBJECTIVE Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established neurosurgical treatment for the motor symptoms of Parkinson’s disease (PD). While often highly effective, DBS does not always yield optimal therapeutic outcomes, and stimulation-induced adverse effects, including paresthesia, muscle contractions, and nausea/lightheadedness, commonly occur and can limit the efficacy of stimulation. Currently, objective metrics do not exist for monitoring neural changes associated with stimulation-induced therapeutic and adverse effects. METHODS In the present study, the authors combined intraoperative functional MRI (fMRI) with STN DBS in 20 patients with PD to test the hypothesis that stimulation-induced blood oxygen level–dependent signals contained predictive information concerning the therapeutic and adverse effects of stimulation. RESULTS As expected, DBS resulted in blood oxygen level–dependent activation in myriad motor regions, including the primary motor cortex, caudate, putamen, thalamus, midbrain, and cerebellum. Across the patients, DBS-induced improvements in contralateral Unified Parkinson’s Disease Rating Scale tremor subscores correlated with activation of thalamic, brainstem, and cerebellar regions. In addition, improvements in rigidity and bradykinesia subscores correlated with activation of the primary motor cortex. Finally, activation of specific sensorimotor-related subregions correlated with the presence of DBS-induced adverse effects, including paresthesia and nausea (cerebellar cortex, sensorimotor cortex) and unwanted muscle contractions (caudate and putamen). CONCLUSIONS These results suggest that DBS-induced activation patterns revealed by fMRI contain predictive information with respect to the therapeutic and adverse effects of DBS. The use of fMRI in combination with DBS therefore may hold translational potential to guide and improve clinical stimulator optimization in patients.